相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Development of Human Monoclonal Antibody for Claudin-3 Overexpressing Carcinoma Targeting
Hobin Yang et al.
BIOMOLECULES (2020)
Stability and Activity of the Hyperglycosylated Human Interferon-beta R27T Variant
Kyoung Song et al.
SCIENTIFIC REPORTS (2020)
Characterization of human cancer xenografts in humanized mice
Jonathan Rios-Doria et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Cytokines in the Treatment of Cancer
Kevin C. Conlon et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2019)
Interferons α and β in cancer: therapeutic opportunities from new insights
Ernest C. Borden
NATURE REVIEWS DRUG DISCOVERY (2019)
A Glycoengineered Interferon-β Mutein (R27T) Generates Prolonged Signaling by an Altered Receptor-Binding Kinetics
Saehyung Lee et al.
FRONTIERS IN PHARMACOLOGY (2019)
Reduction of IL-2 fragmentation during manufacturing of a novel immunocytokine by DoE process optimization
Alina Schneider et al.
BIOTECHNOLOGY AND BIOENGINEERING (2019)
Antibody structure and engineering considerations for the design and function of Antibody Drug Conjugates (ADCs)
Ricarda M. Hoffmann et al.
ONCOIMMUNOLOGY (2018)
Forty-nine gastric cancer cell lines with integrative genomic profiling for development of c-MET inhibitor
Hyun Jeong Kim et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Disruption of IFN-I Signaling Promotes HER2/Neu Tumor Progression and Breast Cancer Stem Cells
Luciano Castiello et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Humanized Mice for the Study of Immuno-Oncology
Philippe De La Rochere et al.
TRENDS IN IMMUNOLOGY (2018)
Found in Translation: Maximizing the Clinical Relevance of Nonclinical Oncology Studies
Mary E. Spilker et al.
CLINICAL CANCER RESEARCH (2017)
The immune contexture in cancer prognosis and treatment
Wolf H. Fridman et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Sensitization of glycoengineered interferon-β1a-resistant cancer cells by cFLIP inhibition for enhanced anti-cancer therapy
Tae-Eun Kim et al.
ONCOTARGET (2017)
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
Angel Garcia-Diaz et al.
CELL REPORTS (2017)
Anti-VEGFR2-interferon-α2 regulates the tumor microenvironment and exhibits potent antitumor efficacy against colorectal cancer
Zhaoting Li et al.
ONCOIMMUNOLOGY (2017)
Targeting Attenuated Interferon-α to Myeloma Cells with a CD38 Antibody Induces Potent Tumor Regression with Reduced Off-Target Activity
Sarah L. Pogue et al.
PLOS ONE (2016)
Overcoming rituximab drug-resistance by the genetically engineered anti-CD20-hIFN-α fusion protein: Direct cytotoxicity and synergy with chemotherapy
Gabriel G. Vega et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Targeting the Tumor Microenvironment with Interferon-β Bridges Innate and Adaptive Immune Responses
Xuanming Yang et al.
CANCER CELL (2014)
Subtype-dependent prognostic relevance of an interferon-induced pathway metagene in node-negative breast cancer
Maurizio Callari et al.
MOLECULAR ONCOLOGY (2014)
Bridging the Species Divide: Transgenic Mice Humanized for Type-I Interferon Response
Daniel Harari et al.
PLOS ONE (2014)
Glycoengineering of Interferon-β 1a Improves Its Biophysical and Pharmacokinetic Properties
Kyoung Song et al.
PLOS ONE (2014)
Antibody-Cytokine Fusion Proteins for Treatment of Cancer: Engineering Cytokines for Improved Efficacy and Safety
Patricia A. Young et al.
SEMINARS IN ONCOLOGY (2014)
NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17)
Rizwan Romee et al.
BLOOD (2013)
Membrane-Type 6 Matrix Metalloproteinase Regulates the Activation-Induced Downmodulation of CD16 in Human Primary NK Cells
Giovanna Peruzzi et al.
JOURNAL OF IMMUNOLOGY (2013)
Anti-CD20-Interferon-β Fusion Protein Therapy of Murine B-Cell Lymphomas
Kham R. Trinh et al.
JOURNAL OF IMMUNOTHERAPY (2013)
Preclinical safety profile of trastuzumab emtansine (T-DM1): Mechanism of action of its cytotoxic component retained with improved tolerability
Kirsten Achilles Poon et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
Impaired IFN-α Production by Plasmacytoid Dendritic Cells Favors Regulatory T-cell Expansion That May Contribute to Breast Cancer Progression
Vanja Sisirak et al.
CANCER RESEARCH (2012)
Direct Effects of Type I Interferons on Cells of the Immune System
Sandra Hervas-Stubbs et al.
CLINICAL CANCER RESEARCH (2011)
Intratumoral injection of interferon-alpha and systemic delivery of agonist anti-CD137 monoclonal antibodies synergize for immunotherapy
Juan Dubrot et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Anti-ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti-PD-1 or anti-CD137 mAb therapy
John Stagg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Targeted delivery of interferon-alpha via fusion to anti-CD20 results in potent antitumor activity against B-cell lymphoma
Caiyun Xuan et al.
BLOOD (2010)
High productivity of human recombinant beta-interferon from a low-temperature perfusion culture
J. Rodriguez et al.
JOURNAL OF BIOTECHNOLOGY (2010)
APC Activation by IFN-α Decreases Regulatory T Cell and Enhances Th Cell Functions
Luigia Pace et al.
JOURNAL OF IMMUNOLOGY (2010)
Expression, engineering and characterization of the tumor-targeting heterodimeric immunocytokine F8-IL12
Roberto Sommavilla et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2010)
Enhanced Interferon-β Production by CHO Cells Through Elevated Osmolality and Reduced Culture Temperature
Young Kue Han et al.
BIOTECHNOLOGY PROGRESS (2009)
CD20-targeted tetrameric interferon-α, a novel and potent immunocytokine for the therapy of B-cell lymphomas
Edmund A. Rossi et al.
BLOOD (2009)
Correlation between NK function and response to trastuzumab in metastatic breast cancer patients
Alessandra Beano et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2008)
Interferons at age 50: past, current and future impact on biomedicine
Ernest C. Borden et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Targeting IFN-α to B cell lymphoma by a tumor-specific antibody elicits potent antitumor activities
Tzu-Hsuan Huang et al.
JOURNAL OF IMMUNOLOGY (2007)
Defective Jak-Stat activation in renal cell carcinoma is associated with interferon-α resistance
Donghao Shang et al.
CANCER SCIENCE (2007)
Molecular and functional evidence for activity of murine IL-7 on human lymphocytes
Joao T. Barata et al.
EXPERIMENTAL HEMATOLOGY (2006)
Enhanced production of monomeric interferon-ss by CHO cells through the control of culture conditions
J Rodriguez et al.
BIOTECHNOLOGY PROGRESS (2005)
Effects of Helicobacter pylori on intracellular Ca2+ signaling in normal human gastric mucous epithelial cells
KL Marlink et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2003)
Adenovirus-mediated gene transfer of interferon α improves dimethylnitrosamine-induced liver cirrhosis in rat model
K Suzuki et al.
GENE THERAPY (2003)
Novel growth and death related interferon-stimulated genes (ISGs) in melanoma: Greater potency of IFN-beta compared with IFN-alpha 2
DW Leaman et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2003)
Interleukin-15 interactions with interleukin-15 receptor complexes: Characterization and species specificity
J Eisenman et al.
CYTOKINE (2002)
Effect of interferon-α on CD20 antigen expression of B-cell chronic lymphocytic leukemia
S Sivaraman et al.
CYTOKINES CELLULAR & MOLECULAR THERAPY (2000)
分享论文
